ABOUT US Since its establishment in 2014, KMD Bioscience (Tianjin) Co., Ltd. has been committed to becoming a leading provider of drug antibody discovery, aptamer screening services, and related support. We focus on technology R&D, delivering high-quality CRO services to scientists and research institutions worldwide to advance pharmaceutical innovation. As a national patent pilot high-tech enterprise, we continuously expand our expertise and technical platforms to support global drug development.
Aptamer Screening Services for Protein
has an experienced team of technical staff to provide aptamer screening services for different targets ranging from purified proteins to whole cells and tissues. We are committed to providing our custaptamer screening service:Leverage the latest technologies to identify antibodies suitable for your application.
Integrated high-throughput antibody characterization to advance drug discovery research Surface Plasmon Resonance (SPR) is a powerful analytical technology for analyzing and characterizing antibodies.APTAMER SCREENING SERVICE:Aptamer Development
APTAMER SCREENING SERVICE: Aptamer Development Nucleic acid aptamers are short single-stranded oligonucleotides (ssDNA or ssRNA) that can selectively bind to a specific target with high affinity. A laAptamer screening service:Technical Highlights of the Aptamer Development Process
Technical Highlights of the Aptamer Development Process Aptamer development is centered around the SELEX (Systematic Evolution of Ligands by EXponential enrichment) process. Its key technologicalAptamer screening service:Technical process of Aptamer synthesis
The synthesis of aptamers is not a direct chemical construction from a blueprint, but rather a selection and amplification process from a vast random library. The primary method is called SELEX (Saptamer screening service:Introduction to Nucleic acid aptamers
Introduction to Nucleic Acid Aptamers What Are Aptamers? Nucleic acid aptamers are short, single-stranded DNA or RNA molecules that fold into specific three-dimensional structures, enabling them to bikmdbioscience aptamer screening service:Antigen types for aptamer selection
Excellent question. It's important to clarify terminology first: while aptamers are often selected against targets we classically call "antigens" (e.g., proteins on pathogens), the term "antigen" (akmdbioscience aptamer screening service:SELEX Technology for Aptamer Screening
What is SELEX? SELEX (Systematic Evolution of Ligands by EXponential enrichment) is an in vitro combinatorial chemistry technique used to isolate high-affinity, high-specificity nucleic acid ligandaptamer screening service:an Efficient Method for Discovering Specific Binding Molecules
Nucleic Acid Aptamer Libraries Screening: an Efficient Method for Discovering Specific Binding Molecules Aptamers are oligonucleotide sequences (DNA or RNA) consisting of 20-110 nucleotides. AptamersKMD Bioscience Aptamer Screening Service:Aptamer Screening for Small Molecule Service Process
Aptamer Screening for Small Molecule Service Processkmdbioscience Aptamer Screening Service ：Aptamer Screening Techniques for Small Molecule
For small molecule targets specifically, Solid-Phase SELEX (using magnetic beads) and CE-SELEX are currently the most prominent and effective strategies, with CE-SELEX offering significant advantKMD Bioscience Aptamer Screening Service:Aptamer Screening for Small Molecule Targets
Core Challenge with Small Molecules Small molecules (e.g., drugs, toxins, metabolites, <1000 Da) lack the large, multi-epitope surfaces of proteins. This makes traditional selection methods difficuKMD Bioscience Aptamer Screening Service: A Comprehensive Workflow
Aptamer Selection Small molecule aptamer screening techniques generally include the following steps: A. Initial library design: Build a DNA, RNA or peptide library containing a large number of randomKMD Bioscience Aptamer Screening Service: Aptamer Types
KMD Bioscience's aptamer screening service covers all the above types. Depending on your target characteristics and research objectives (e.g., diagnostics, therapeutics, assay development), we providekmdbioscience Aptamer Screening for Small Molecule
With the continuous progress of biotechnology and computing technology, small molecule aptamer screening technology will play an important role in more fields. For example, in drug development, aptameKmdbioscience Aptamer Screening Service
Kmdbioscience Aptamer Screening Service We offer comprehensive in vitro aptamer screening services, enabling rapid and accurate identification of aptamers with high affinity and specificity to help clAptamer Screening Service: Key Features
Our current screening success rate stands at approximately 80%. Please be aware that developing aptamers for small-sized proteins or small chemical molecules remains particularly challenging. We are captamer screening service:Aptamer Development Service Workflow
Custom Aptamer Discovery Service: Our Tailored Development Process Curious about how we identify precision-targeting aptamers? Our step-by-step workflow is designed to isolate high-affinity molecularaptamer screening service:Aptamer Development
Nucleic acid aptamers are short, single-stranded oligonucleotides (ssDNA or ssRNA) capable of binding with high affinity and specificity to diverse targets, ranging from small molecules and proteins taptamer screening service:Aptamer Design & Synthesis
Custom-Tailored Aptamers with Exceptional Affinity and Specificity for Your Target Molecules Aptamers are powerful tools in biotechnology and therapeutic development, offering molecular recognitionAntigen screening quickly detects specific proteins to identify active infections providing rapid results for early...
Small molecule screening tests thousands of compounds to identify potential drugs that modulate a specific...
Aptamer Selection is the process of identifying synthetic DNA or RNA molecules (aptamers) that bind with high affinity and specificity to a target of interest, such as a protein...
Aptamer screening isolates specific nucleic acids that bind tightly to a target molecule, like proteins or cells, through an iterative selection process called SELEX.
Peptide Services Auburn Alabama – High-Quality Research Peptides from KMDbioscience.org Researchers, biotechnology companies, and academic laboratories in Auburn, Alabama increasingly depend on prec
Custom Peptides Auburn AL – Reliable China-Based Supplier Serving the USA Market Researchers and biotechnology companies in Auburn, Alabama increasingly depend on high-purity custom peptides for dru
Peptide Research Tuscaloosa: High-Purity Custom Peptide Solutions from a China-Based Supplier Serving the USA Peptide research continues to play a central role in biomedical innovation, drug discovery
Peptide Synthesis Services Mobile, USA – High-Purity Custom Peptides from China-Based Supplier KMDBioScience Introduction Researchers, biotech companies, and pharmaceutical developers in Mobile, Ala
Peptides Mobile Supplier for USA Laboratories – Quality from a China-Based Factory Peptides Mobile is becoming a preferred solution for research institutes, biotech companies, pharmaceutical develop
Leading Peptide Manufacturer Supplying Mobile, Alabama – High-Purity Peptides from KMDBioscience.org Researchers, biotech companies, pharmaceutical developers, and diagnostic laboratories in Mobile,
Custom Peptide Synthesis Montgomery – High-Purity Research Peptides from China-Based KMDBioscience Research institutions, biotechnology labs, and pharmaceutical developers in Montgomery, Alabama inc
Peptide Screening Montgomery: Advanced Research Solutions from China-Based Supplier KMD Bioscience Researchers and pharmaceutical innovators in Montgomery, Alabama increasingly rely on precise, data-d
Aptamer Selection is the process of identifying synthetic DNA or RNA molecules (aptamers) that bind with high affinity and specificity to a target of interest, such as a protein, small molecule, or cell. This is primarily achieved through an iterative laboratory technique called SELEX (Systematic Evolution of Ligands by EXponential enrichment), which enriches specific binding sequences from a vast random library over multiple rounds.
Get a Sample
Peptide-Drug Conjugates (PDCs) are targeted therapeutics that chemically link a biologically active drug (“payload”) to a peptide that guides the payload toward a specific receptor, microenvironment, or cellular compartment. Conceptually, PDCs resemble Antibody–Drug Conjugates (ADCs), but replace the antibody with a peptide, aiming to keep targeting precision while improving tissue penetration, manufacturing accessibility, and design flexibility. 1) What Exactly Is a PDC (and Why It Matters)? A typical PDC is built from three modular parts: Targeting peptide (the “homing” component) Linker (the chemical bridge that controls stability and payload release) Payload (cytotoxic drug, radionuclide, or other potent therapeutic)…
Venture capital interest in AI-driven drug discovery has moved from “promise” to a more disciplined phase of investment & funding. Capital is still available, but it increasingly concentrates in teams and platforms that can prove (1) credible biology, (2) proprietary data advantage, and (3) a realistic path to value creation—whether through licensing, partnerships, or clinical progression. Recent industry tracking highlights a rebound in AI funding within drug R&D and emphasizes that “discovery engines” have captured a significant share of investment attention. This article explains the category in a knowledge-first way: what investors look for, common funding structures, due diligence…
